KK and KK-A y mice serve as animal models of non-insulin-dependent diabetes mellitus with moderate obesity. Quantitative trait locus (QTL) analysis was performed to identify gene loci that account for fasting hyperglycemia, glucose intolerance and plasma insulin in 91 F 2 females of a C57BL=6JÂKK-A y intercross. For glucose intolerance, a significant QTL was identified on chromosome 8, with a maximum lod score of 5.6. This locus had strong influence on the late phase of the intraperitoneal glucose tolerance test (IPGTT), suggesting that the locus may have role in glucose clearance rather than in mere hyperglycemia. In addition, three suggestive QTLs were identified on chromosomes 1 (fasting glucose), 3 (fasting insulin) and 4, (blood glucose at 120 min during IPGTT, and glucose intolerance).
Introduction
The inbred mouse KK strain develops non-insulindependent diabetes mellitus (NIDDM) with moderate obesity.
1,2 KK-A y , a congenic strain of the A y allele at the agouti locus, also develops NIDDM that is more severely expressed than that in KK. 3 We previously analyzed NIDDM-related traits in F 2 progeny of a cross between normoglycemic C57BL=6J and KK-A y mice. 4 In consequence, several quantitative trait loci (QTLs) were identified for NIDDM traits; however, only two suggestive QTLs were identified for glucose intolerance on chromosomes 1 and 8. Because the A y allele causes massive obesity, F 2 -a=a mice and F 2 -A y =a mice were analyzed separately on the basis of genotypes at the agouti locus. 5 Each F 2 group comprised both males and females. Although there were no statistically significant interactions between sex and marker locus genotype at the QTL region, there were gender specificities in some traits (eg plasma lipid analysis 6 ), and a difference of mean values between genotypes at the QTL region tended to be larger in females than in males, as a rule. Here, we report the results of QTL analysis for NIDDM by analyzing F 2 female mice.
Methods
Experimental procedures have been described previously. 4 In brief, C57BL=6J females were crossed with KK-A y males to produce F 1 -A y mice, which were intercrossed to produce two kinds of F 2 with regard to the agouti locus; that is, F 2 -a=a and F 2 -A y =a. An intraperitoneal glucose tolerance test (IPGTT) was conducted on 91 F 2 females (42 F 2 -a=a and 49 F 2 -A y =a) at the age of 20 weeks (148 AE 5 days in a=a and 135 AE 3 days in A y =a). Glucose (mg=dl) was measured in blood from tail bleeds at 0, 30, 60 and 120 min during IPGTT. The glucose area under the curve (AUC, mg=dl min) was calculated as an indication of impaired glucose tolerance according to the trapezoid rule from the glucose measurements at 0, 30, 60 and 120 min. At 0 and 30 min during IPGTT, plasma insulin was also determined. In order to merge F 2 -a=a and F 2 -A y =a, we standardized phenotypic values for the F 2 -a=a group and F 2 -A y =a group by subtracting the group-specific mean from each individual value and dividing each difference by the standard deviation of its respective group. QTL analysis was carried out with the Mapmaker=EXP and Mapmaker=QTL programs. 7, 8 In total, 97 autosomal microsatellite markers were genotyped; the average marker density was 16.5 cM (1600=97).
Results and discussion
According to two-way ANOVA, there were no statistically significant interactions between agouti locus genotype and marker locus genotype at the putative QTL region for all traits examined. For fasting glucose, a suggestive QTL was identified on distal chromosome 1, near D1Mit150, with an logarithm of odds (lod) score of 3.6. For AUC (glucose intolerance), a significant QTL was identified on chromosome 8, near D8Mit191, with an lod score of 5.6 (24.5% of the F 2 variance; P < 0.000005 in standardized values, Figure  1 ). We named this locus Giq1 (glucose intolerance QTL 1). As to the Giq1, peak lod scores for glucose at 30 min during IPGTT were 2.1, at 60 min 4.4 (20.0% of variance; P < 0.00006), and at 120 min 5.0 (23.6% of variance; P < 0.00002; Figure 1 ). The Giq1 thus has a strong influence on the late phase of IPGTT, suggesting that the Giq1 may have role in glucose clearance rather than in mere hyperglycemia (Table 1 ). There are several candidate gene loci around Giq1, such as neuropeptide Y receptor Y5 (Npy5r, 32.5 cM), carboxypeptidase E (Cpe, 32.6), lipoprotein lipase (Lpl, 33.0), and uncoupling protein (Ucp, 38.0). 9 The Giq1 seems to be a novel QTL for the murine NIDDM model, and the D8Mit191 position corresponds to human cytogenetic positions of 3p22 -p21.3 or 8p22 -21.3. 9 In addition, a suggestive QTL for AUC was identified on chromosome 4, near D4Mit166 (44.5 cM), with an lod score of 2.9. This locus was also a suggestive QTL for glucose at 120 min, with an lod score of 3.4. The leptin receptor (Lepr) has been mapped to this region (46.7 cM). 9 In fact, a Lepr variant of Asp600Asn has Glucose intolerance QTL on murine chromosome 8 J Suto and K Sekikawa been reported in KK, and this variant is suggested to be associated with some adipose tissue weight in F 2 females of a C57BL=6JÂKK intercross. 10 Regarding the above-mentioned traits, the KK allele was associated with increased glucose. For fasting plasma insulin, a suggestive QTL was identified on distal chromosome 3, near D3Mit84, with an lod score of 3.9. At this locus, the C57BL=6J allele was associated with increased insulin. Even a suggestive QTL was not identified for insulin at 30 min after glucose loading. A genome wide linkage curve for AUC is shown in Figure 2 .
Recently, Shike et al 11 identified a significant QTL for glucose intolerance on proximal chromosome 6, and two significant QTLs for fasting glucose on chromosomes 12 and 15, using male progeny of a KKÂ(BALB=cÂKK) F 1 backcross. The discrepancies between the studies could be attributed to a difference in the strain used as a normoglycemic counterpart or to gender specificities.
Finally, F 2 -a=a and F 2 -A y =a differ phenotypically from each other in several respects. Whereas F 2 -A y =a were obese (average body weight 52.0 g) and all mice developed hypertrophy of the islet (data not shown) with hyperinsulinemia, F 2 -a=a were not so obese (average body weight 32.3 g) and did not develop islet hypertrophy. Despite these differences, the genetic basis that accounts for glucose intolerance by the allele at Giq1 was the same in a=a and A y =a. Therefore, it is suggested that hyperinsulinemia or obesity per se is not likely to be a primary defect resulting in glucose intolerance in KK and KK-A y mice.
